Form 4: Teleflex Director Jaewon Ryu Reports Stock Award and Option Grant

Director Jaewon Ryu reports acquisition of restricted stock units and stock options in Teleflex Inc.

Summary

• Jaewon Ryu, a director of Teleflex Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On May 9, 2025, Ryu was granted 1,051 shares of common stock as a restricted stock unit award under the company's 2023 Stock Incentive Plan.
• These restricted stock units vest on the one-year anniversary of the grant date, or earlier if Ryu does not stand for re-election at the 2026 annual meeting, provided that meeting is held at least 50 weeks after the 2025 meeting.
• Also on May 9, 2025, Ryu was granted a stock option to purchase 2,226 shares of common stock at an exercise price of $125.11, expiring on May 9, 2035.
• The stock option vests on May 9, 2026, or earlier if Ryu does not stand for re-election at the 2026 annual meeting, provided that meeting is held at least 50 weeks after the 2025 meeting.
• Following these transactions, Ryu directly owns 2,226 derivative securities and 2,227 shares of Teleflex Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of incentivizing directors with equity, suggesting a positive outlook on the director's continued contributions and alignment with shareholder interests. There are no overtly negative aspects presented.

Positives

• The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
• The vesting conditions tied to re-election may incentivize the director to remain engaged with the company.

Risks

• The value of the stock options is dependent on the future performance of Teleflex Inc.'s stock price.
• The vesting of the awards is contingent on Ryu's continued service as a director and specific re-election conditions.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the equity grants suggest an expectation of continued contributions from the director.

Industry Context

Equity grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders. The specific terms of the grants, such as vesting schedules and performance conditions, can vary widely depending on the company and industry.

Comparison to Industry Standards

• Stock option grants to directors are a common practice among publicly traded companies, including those in the medical device industry like Medtronic and Boston Scientific.
• The size of the grant and the vesting schedule are generally aligned with industry standards for companies of similar size and market capitalization.
• The exercise price of $125.11 would need to be compared to the current market price of Teleflex stock to determine the potential value of the options.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning the director's interests with the company's long-term success.
• Employees may see the grants as a sign of confidence in the company's future.

Key Dates

Keywords

Teleflex, Director, Stock Option, Restricted Stock Unit, Beneficial Ownership, Form 4, Ryu